Oragenics Inc. (OGEN) is a publicly traded Healthcare sector company. As of November 12, 2026, OGEN trades at $0.30 with a market cap of $1.54M and a P/E ratio of -0.11. OGEN moved -7.21% today. Year to date, OGEN is -59.03%; over the trailing twelve months it is -69.14%. Its 52-week range spans $0.34 to $9.60. Rallies surfaces OGEN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Oragenics gets NYSE American extension to February 2028 to regain listing compliance: NYSE Regulation accepted Oragenics’ compliance plan on Nov. 11, 2026, giving the company until Feb. 25, 2028, to meet listing standards. Its shares will remain listed during the period, subject to plan milestones and ongoing reviews.
| Metric | Value |
|---|---|
| Price | $0.30 |
| Market Cap | $1.54M |
| P/E Ratio | -0.11 |
| EPS | $-4.56 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.60 |
| 52-Week Low | $0.34 |
| Volume | 7.45K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-9.84M |
| Gross Margin | 0.00% |
OGEN analyst coverage data. Average price target: $0.00.